Αποτελέσματα αναζήτησης - "ВТОРИЧНАЯ ПРОФИЛАКТИКА ИШЕМИЧЕСКОГО ИНСУЛЬТА"

1

Academic Journal

Transient global amnesia as a clinical manifestation of unilateral hippocampal infarction. Case report ; Транзиторная глобальная амнезия как клиническое проявление одностороннего инфаркта гиппокампа. Описание клинического случая

Συγγραφείς: O. O. Martynova, V. V. Zakharov, О. О. Мартынова, В. В. Захаров

Συνεισφορές: The investigation has not been sponsored, Исследование не имело спонсорской поддержки

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 6 (2023); 95-100 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 6 (2023); 95-100 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-6

Θεματικοί όροι: дипиридамол, transient global amnesia, secondary prevention of ischemic stroke, dipyridamole, транзиторная глобальная амнезия, вторичная профилактика ишемического инсульта

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2144/1611; Sander D, Bartsch T, Connolly F, et al. Guideline “Transient Global Amnesia (TGA)” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): S1-guideline. Neurol Res Pract. 2023 Apr 20;5(1):15. doi:10.1186/s42466-023-00240-0. Erratum in: Neurol Res Pract. 2023 Nov 8;5(1):64.; Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):834-43. doi:10.1136/jnnp.53.10.834; Lauria G, Gentile M, Fassetta G, et al. Incidence of transient global amnesia in the Belluno province, Italy: 1985 through 1995. Results of a community-based study. Acta Neurol Scand. 1997 May;95(5):303-10. doi:10.1111/j.1600-0404.1997.tb00215.x; Miller JW, Petersen RC, Metter EJ, et al. Transient global amnesia: clinical characteristics and prognosis. Neurology. 1987 May;37(5):7337. doi:10.1212/wnl.37.5.733; Koski KJ, Marttila RJ. Transient global amnesia: incidence in an urban population. Acta Neurol Scand. 1990 Apr;81(4):358-60. doi:10.1111/j.1600-0404.1990.tb01571.x; Alessandro L, Calandri IL, Suarez MF, et al. Transient global amnesia: clinical features and prognostic factors suggesting recurrence. Arq Neuropsiquiatr. 2019 Jan;77(1):3-9. doi:10.1590/0004-282X20180157; Komulainen T, Bärlund V, Tanila H, et al. Incidence and Risk Factors of Transient Global Amnesia. Neuroepidemiology. 2023;57(4):24652. doi:10.1159/000530713. Epub 2023 May 15.; Akkawi NM, Agosti C, Grassi M, et al. Weather conditions and transient global amnesia. A six-year study. J Neurol. 2006 Feb;253(2):194-8. doi:10.1007/s00415-0050952-3. Epub 2005 Aug 24.; Keret O, Lev N, Shochat T, Steiner I. Seasonal Changes in the Incidence of Transient Global Amnesia. J Clin Neurol. 2016 Oct;12(4):403-6. doi:10.3988/jcn.2016.12.4.403. Epub 2016 Apr 19.; Caplan L. Transient global amnesia. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of Clinical Neurology. Amsterdam: Elsevier Science Publishers; 1985. Vol. 45. P. 205-18.; Hodges JR, Warlow CP. The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain. 1990 Jun;113 ( Pt 3):639-57. doi:10.1093/brain/113.3.639; Lanzone J, Ricci L, Assenza G, et al. Transient epileptic and global amnesia: Real-life differential diagnosis. Epilepsy Behav. 2018 Nov;88:205-11. doi:10.1016/j.yebeh.2018.07.015. Epub 2018 Oct 5.; Michel D, Garnier P, Schneider F, et al. Diffusion MRI in pure transient global amnesia associated with bilateral vertebral artery dissection. Cerebrovasc Dis. 2004;17(2-3):264-6. doi:10.1159/000076964. Epub 2004 Feb 23.; Gass A, Gaa J, Hirsch J, et al. Lack of evidence of acute ischemic tissue change in transient global amnesia on single-shot echo-planar diffusion-weighted MRI. Stroke. 1999 Oct;30(10):2070-2. doi:10.1161/01.str.30.10.2070; Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41. doi:10.1161/01.str.24.1.35; Bartsch T, Deuschl G. Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol. 2010 Feb;9(2):205-14. doi:10.1016/S1474-4422(09)70344-8; Mazzoni M, Del Torto E, Vista M, Moretti P. Transient topographical amnesia: a case report. Ital J Neurol Sci. 1993 Dec;14(9):633-6. doi:10.1007/BF02339248; Cammalleri R, Gangitano M, D'Amelio M, et al. Transient topographical amnesia and cingulate cortex damage: a case report. Neuropsychologia. 1996 Apr;34(4):321-6. doi:10.1016/0028-3932(95)00108-5; Ишемический инсульт и транзиторная ишемическая атака у взрослых: клинические рекомендации. Москва: Минздрав РФ; 2021.; Старчина ЮА, Захаров ВВ. Когнитивные нарушения при артериальной гипертензии. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):113-8. doi:10.14412/2074-2711-2021-1-113-118; Johnston SC, Easton JD, Farrant M, et al; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215-25. doi:10.1056/NEJMoa1800410. Epub 2018 May 16.; Wang Y, Wang Y, Zhao X, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. doi:10.1056/NEJMoa1215340. Epub 2013 Jun 26.; Фонякин АВ, Гераскина ЛА, Максимова МЮ. Антитромбоцитарная терапия в профилактике инсульта после транзиторной ишемической атаки некардиоэмболического генеза. Неврология, нейропсихиатрия, психосоматика. 2021;13(5):14-9. doi:10.14412/2074-2711-2021-5-14-19; Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Dipyridamole: a drug with unrecognized antioxidant activity. Curr Top Med Chem. 2015;15(9):822-9. doi:10.2174/1568026615666150220111942; Chakrabarti S, Blair P, Wu C, Freedman JE. Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects. J Cardiovasc Pharmacol. 2007 Oct;50(4):449-57. doi:10.1097/FJC.0b013e31813542db; Таняшян ММ, Домашенко МА. Применение курантила при хронических цереброваскулярных заболеваниях. Атмосфера. Нервные болезни. 2005;(3):8-11.; Таняшян ММ, Домашенко МА. Дипиридамол в комплексной терапии хронических цереброваскулярных заболеваний. Атмосфера. Нервные болезни. 2012;(3):27-30.

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/2144
https://doi.org/10.14412/2074-2711-2023-6-95-100

View record from BASE

2

Academic Journal

Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke ; Возможности антитромбоцитарной терапии при некардиоэмболическом ишемическом инсульте

Συγγραφείς: M. Yu. Maksimova, A. S. Airapetova, М. Ю. Максимова, А. С. Айрапетова

Συνεισφορές: The investigation has been conducted within the framework of the government program for the Federal State Budgetary Scientific Institution «Scientific Center of Neurology»., Работа выполнена в рамках государственного задания ФГБНУ «Научный центр неврологии».

Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 14, No 3 (2022); 81-86 ; Неврология, нейропсихиатрия, психосоматика; Vol 14, No 3 (2022); 81-86 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2022-3

Θεματικοί όροι: вторичная профилактика ишемического инсульта, non-cardioembolic stroke, secondary prevention of ischemic stroke, некардиоэмболический инсульт

Περιγραφή αρχείου: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1828/1420; GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):439-58. doi:10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11.; Flach C, Muruet W, Wolfe CDA, et al. Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study. Stroke. 2020 Aug;51(8):2435-44. doi:10.1161/STROKEAHA.120.028992. Epub 2020 Jul 10.; Парфенов ВА, Вербицкая СВ. Антитромбоцитарная терапия во вторичной профилактике ишемического инсульта. Медицинский совет. 2015;(5):6-13. doi:10.21518/2079-701X-2015-5-6-13; Парфенов ВА, Вербицкая СВ. Профилактика повторного некардиоэмболического ишемического инсульта на основе антитромбоцитарных средств. Атеротромбоз. 2016;(2):89-97. doi:10.21518/2307-1109-2016-2-89-97; Пирадов МА, Танашян ММ, Максимова МЮ, редакторы. Инсульт: cовременные технологии диагностики и лечения: Руководство для врачей. Москва: МЕДпресс-информ; 2018. 360 с.; Домашенко МА, Максимова МЮ, Танашян ММ. Современный взгляд на назначение антиагрегантных препаратов для вторичной профилактики некардиоэмболического ишемического инсульта. Эффективная фармакотерапия. 2018;24:82-6.; Суслина ЗА, Высоцкая ВГ. Антиагрегационное действие и клинический эффект малых доз аспирина при лечении больных с цереброваскулярной патологией на фоне артериальной гипертензии. Клиническая медицина. 1983;6(9):51-9.; International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997 May 31;349(9065):1569-81.; CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997 Jun 7;349(9066):1641-9.; Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30;373(9678):1849-60. doi:10.1016/S0140-6736(09)60503-1; Goyan JE. The “trials” of a long-term clinical trial: the Ticlopidine Aspirin Stroke Study and the Canadian-American Ticlopidine Study. Control Clin Trials. 1989;10(4 Suppl):236S-244S. doi:10.1016/0197-2456(89)90062-7; CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329-39. doi:10.1016/s0140-6736(96)09457-3; Diener HC, Bogousslavsky J, Brass LM, et al; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331-7. doi:10.1016/S0140-6736(04)16721-4; Bhatt DL, Flather MD, Hacke W, et al; CHARISMA Investigators. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007 May 15;49(19):1982-8. doi:10.1016/j.jacc.2007.03.025. Epub 2007 Apr 11.; Wang Y, Pan Y, Zhao X, et al; CHANCE Investigators. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. Circulation. 2015 Jul 7;132(1):40-6. doi:10.1161/CIRCULATIONAHA.114.014791. Epub 2015 May 8.; Amarenco P, Albers GW, Denison H, et al; SOCRATES Steering Committee and Investigators. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol. 2017 Apr;16(4):301-10. doi:10.1016/S1474-4422(17)30038-8. Epub 2017 Feb 23.; Johnston SC, Amarenco P, Denison H, et al; THALES Investigators. The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design. Int J Stroke. 2019 Oct;14(7):745-51. doi:10.1177/1747493019830307. Epub 2019 Feb 12.; Best LC, McGuire MB, Jones PB, et al. Mode of action of dipyridamole on human platelets. Thromb Res. 1979;16(3-4):367-79. doi:10.1016/0049-3848(79)90084-7; Wang C, Lin W, Playa H, et al. Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4). Biochem Pharmacol. 2013 Dec 1;86(11):1531-40. doi:10.1016/j.bcp.2013.08.063. Epub 2013 Sep 7.; Dresse A, Chevolet C, Delapierre D, et al. Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man. Eur J Clin Pharmacol. 1982;23(3):229-34. doi:10.1007/BF00547559; German DC, Kredich NM, Bjornsson TD. Oral dipyridamole increases plasma adenosine levels in human beings. Clin Pharmacol Ther. 1989 Jan;45(1):80-4. doi:10.1038/clpt.1989.12; Kerndt CC, Nagalli S. Dipyridamole. 2021. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.2021 Nov 25.; Карева ЕН. Особенности фармакологического действия и применения дипиридамола в профилактике и лечении вирусных инфекций. Consilium Medicum. 2016;18(12):80-7. doi:10.26442/2075-1753_2016.12.80-87; Kim JA, Tran ND, Zhou W, Fisher M. Dipyridamole enhances tissue plasminogen activator release by brain capillary endothelial cells. Thromb Res. 2005;115(5):435-8. doi:10.1016/j.thromres.2004.10.001. Epub 2004 Nov 5.; Costantini V, Talpacci A, Bastiano ML, et al. Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study. Biomed Biochim Acta. 1990;49(4):263-71.; Long Y, Xia JY, Chen SW, et al. ATP2B1 gene Silencing Increases Insulin Sensitivity through Facilitating Akt Activation via the Ca2+/calmodulin Signaling Pathway and Ca2+-associated eNOS Activation in Endothelial Cells. Int J Biol Sci. 2017 Sep 5;13(9):1203-12. doi:10.7150/ijbs.19666. eCollection 2017.; Pirahanchi Y, Dimri M. Biochemistry, Guanylate Cyclase. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.2021 Jul 22.; Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42. doi:10.1161/ATVBAHA.107.160226. Epub 2008 Jan 3.; Chakrabarti S, Vitseva O, Iyu D, et al. The effect of dipyridamole on vascular cellderived reactive oxygen species. J Pharmacol Exp Ther. 2005 Nov;315(2):494-500. doi:10.1124/jpet.105.089987. Epub 2005 Jul 2.; European Stroke Prevention Study. ESPS Group. Stroke. 1990 Aug;21(8):1122-30. doi:10.1161/01.str.21.8.1122; Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996 Nov;143(1-2):1-13. doi:10.1016/s0022-510x(96)00308-5; ESPRIT Study Group; Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006 May 20;367(9523):1665-73. doi:10.1016/S0140-6736(06)68734-5; Diener HC, Sacco RL, Yusuf S, et al; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct;7(10):875-84. doi:10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29.; Sacco RL, Diener HC, Yusuf S, et al; PRoFESS Study Group. Aspirin and extendedrelease dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. doi:10.1056/NEJMoa0805002. Epub 2008 Aug 27.; Weintraub WS. The vascular effects of cilostazol. Can J Cardiol. 2006 Feb;22 Suppl B(Suppl B):56B-60B. doi:10.1016/s0828-282x(06)70987-4; Tornyos D, Balint A, Kupo P, et al. Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review. Life (Basel). 2021 May 15;11(5):447. doi:10.3390/life11050447; Albay CEQ, Leyson FGD, Cheng FC. Dual versus mono antiplatelet therapy for acute non-cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis – updated meta-analysis. BMC Neurol. 2020 Jun 3;20(1):224. doi:10.1186/s12883-020-01808-y; Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. doi:10.1161/STR.0000000000000211. Epub 2019 Oct 30.; Rahman H, Khan SU, Nasir F, et al. Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack. Stroke. 2019 Apr;50(4):947-53. doi:10.1161/STROKEAHA.118.023978; Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi:10.1161/STR.0000000000000375. Epub 2021 May 24.

Διαθεσιμότητα: https://nnp.ima-press.net/nnp/article/view/1828
https://doi.org/10.14412/2074-2711-2022-3-81-86

View record from BASE

3

Academic Journal